Tesla
Dividend Calendar
Stock Rankings
ETF Rankings
Crypto Rankings
See Graham's ranking
4.0
Johnson & Johnson is one of the world’s largest healthcare companies, founded in 1886 by the three Johnson brothers.
The company operates through three main business segments:
Consumer Health Products:
A portfolio focused on personal health and wellness, including beauty care, over-the-counter medicines, baby care, oral hygiene, women’s health, and wound care.
Well-known brands in Brazil include Clean & Clear, Neutrogena, Sundown, Tylenol, Johnson’s Baby, Hypoglós, Listerine, Band-Aid, O.B., Cotonetes, and Acuvue contact lenses.
Pharmaceuticals:
Concentrated in six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolic Disorders, and Pulmonary Hypertension.
Medical Devices:
Products used in orthopedics, surgery, and eye health, including devices for general surgery, biosurgery, cardiovascular treatments, and ophthalmic products.
With a strong global footprint, Johnson & Johnson operates in more than 90 countries and markets its products in over 175.
The company employs over 132,250 people worldwide, distributed across manufacturing plants, research centers, and operational units.
Driven by continuous investment in Research & Development (R&D), Johnson & Johnson has built its reputation through innovation and strategic acquisitions that strengthen its global leadership in the healthcare sector.
History and Founding of Johnson & Johnson
Johnson & Johnson was founded in 1886 in New Jersey, United States, with only 14 employees.
A pioneer in the mass production of sterile medical supplies, the company expanded its operations throughout the 20th century, diversifying its product portfolio and investing in strategic acquisitions.
These expansions positioned Johnson & Johnson as a global leader in pharmaceuticals, medical devices, and consumer health products.
In Brazil, the company began operations in 1933 with the opening of its first factory in the Mooca district of São Paulo. Since then, it has established a solid presence in the Brazilian market with widely recognized and trusted brands.
A key milestone in the company’s trajectory was its listing on the New York Stock Exchange (NYSE), cementing its status as one of the largest healthcare corporations in the world.
In 2021, Johnson & Johnson announced the spin-off of its Consumer Health division, creating a new independent company while retaining its focus on pharmaceuticals and medical devices. This strategic decision aimed to enhance operational efficiency and accelerate innovation.
The company also played a pivotal role during the COVID-19 pandemic, developing a single-dose vaccine approved for emergency use in several countries.
Today, Johnson & Johnson remains a global benchmark in healthcare, recognized for its commitment to research, innovation, and the development of advanced health solutions.
Additional Information
The Company Johnson & Johnson (United States), is listed on NYSE with a market value of $ 581.04 Billions, having an equity of $ 79.28 Billions.
With a total of 132.250 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.
In the last 12 months the Company had a revenue of $ 94.19 Billions, which generated a profit in the amount of $ 26.80 Billions.
As for its main indicators, the Company has a P/E ratio of 21.68, a P/BV ratio of 7.33 and in the last 12 months the dividend yield of JNJ was at 2.13%.
The Company is traded internationally through the ticker JNJ.
